Life Science Investment, M&A, Partnerships Strategy and Execution Services
Independent insight for confident investment decisions, portfolio value creation, M&A strategy and exit readiness.
What We Do
We help early-stage investors, venture capital, growth equity and mid-cap private equity investors assess their deal flow and rank their opportunities across the life sciences and healthcare sector.
We also work directly with funded life science/healthcare companies to develop and implement go to market, M&A and partnership strategies that support organisational growth and delivery of value creation goals.
Our work combines deep sector experience, market and regulatory understanding, founder, stakeholder and management engagement, and proven commercial judgement so investors and leadership teams can move confidently and quickly without losing sight of risk.
Who We Help
We work with investors and life science/healthcare companies that need fast, independent and commercially grounded advice before, during and after investment.
Our support is designed for investors and leadership teams in life science companies where scientific credibility, regulatory pathway, market adoption, reimbursement, competitive intensity and commercial execution all influence exit valuation.
- Early-stage investors assessing spin-out scientific, clinical or platform opportunities
- VC and Growth Equity investors testing roll-up and expansion plans, revenue assumptions and market readiness
- Private Equity investors reviewing commercial performance, scalability and value-creation potential
- Portfolio teams looking for practical support between investment and exit
- Life science/healthcare companies developing go to market plans and implementing M&A and partnership strategies
Our Services
We provide focused support across the complete investor and company growth lifecycles, from strategy development, first-look screening through deep due diligence, post-deal assessment & monitoring, value creation, and exit scenario planning.
- Initial screening and opportunity assessment: fixed-price opinion pieces, founder & stakeholder interviews, opportunity-versus-risk assessment, market and adoption considerations, and clear go/no-go advice.
- Due diligence: end-to-end due diligence process management, including planning and execution across all workstreams, expert review of market potential, market trends, competition, regulatory requirements, business plans, forecasts and commercial readiness, and synthesis of findings into a final board approval deck.
- Post-deal assessment & monitoring: pre-close development of the integration plan, PMI process and Day 1 activities, followed by post-close project management delivered with the team; analysis of the current situation against due diligence findings; and mentoring for founders, C-suite teams and functional teams, with practical challenge on activities, outcomes, KPIs and milestones.
- Value creation: translating diligence findings into cross-functional priorities and workstreams—including commercial, operations, IT and HR alongside action plans and investor-aligned milestones.
- Exit scenario planning: identifying the evidence, strategic positioning and buyer-facing narrative needed to support valuation and exit readiness.
- M&A and Partnership strategy for companies: developing and implementing acquisition, partnership, consolidation or exit strategies for companies
Engagement Models
Our work can be tailored to your specific needs as well as the stage of the opportunity, the depth of analysis and support required. We can provide rapid screening input, structured diligence reports, M&A strategy support or ongoing portfolio and leadership team support.
- Fixed-price screening: rapid first-look assessment to help investors and companies decide whether to progress an opportunity.
- Tailored due diligence: deeper analysis calibrated to deal requirements and organisational capability and bandwidth.
- Portfolio value-creation support: Integration planning pre-close and post close cross-functional project management and mentoring focused on ensuring key investment and deal goals are delivered or exceeded.
- M&A strategy development and implementation: practical support for companies seeking to define strategic priorities, identify acquisition or partnership opportunities, prepare internal decision materials and execute agreed plans.
Why Investors Work With Us
Investors and companies work with us because we can rapidly and effectively combine sector-specific judgement and deliver clear, practical outputs. We professionally challenge assumptions, highlight both upside and risk, and help translate complex scientific and commercial information into clear, actionable plans.
- Independent perspective: wholly objective advice designed to test assumptions and identify risk.
- Life sciences & healthcare focus: understanding of scientific, regulatory, operational, market and commercial drivers.
- Practical outputs: concise written reports and Q&A sessions, clear fact -based recommendations and decision-focused conclusions & support.
Contact
If you are reviewing a life science or healthcare sector investment, preparing for diligence, looking to accelerate portfolio value creation, or developing an M&A strategy, we can provide focused, independent support. Contact us to discuss the opportunity, the decision you need to make, and the level of review or implementation support required.